Definitive Contract 75D30122C15467
- Not listed
- This is a $1,163,408.53 Firm Fixed Price delivery order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to the University of Maryland, Baltimore (UMB) on September 30, 2019. The order is for a cluster-randomized study of target gown and glove use under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Indefinite Quantity (IDIQ) contract. UMB is a large public research university and leading academic...
- This is a $3,127,962.24 cost-plus-fixed-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) on September 15, 2003. The contract, which does not have a set-aside designation, is for "UNIV-MD/SPCMN COLLCT'N" and is scheduled to be completed by March 31, 2010. UMB, the prime contractor, is a major public research university that frequently receives federal funding through contracts and grants to support its...
- This is a $82,000 Delivery Order awarded to the University of Maryland, Baltimore (UMB) by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The contract is issued under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Vehicle (IDV) and has a firm fixed price arrangement. The contract is focused on the SHEPHERD 2021 DOMAIN 1-A010 SENTINEL requirement, which does not have a set-aside designation. As a...
- This firm fixed price delivery order for approximately $180,000 was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to the University of Maryland, Baltimore (UMB) for Sentinel Surveillance of Organisms that can Cause Healthcare-Associated Infections. The contract is being performed under the Safe Healthcare, Epidemiology, and Prevention Research Development Program (SHEPheRD) indefinite-delivery/indefinite-quantity master contract vehicle. UMB will conduct surveillance...
- This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
- This is a firm-fixed-price federal contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) for reducing Clostridioides difficile (C. diff) infection. The contract has a ceiling value of $400,214.53 and an ultimate completion date of March 30, 2018. UMB, the prime contractor, is a major public research university that frequently receives federal funding through contracts and grants to support its research, education, and clinical...
- This is a $750,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, College Park (UMD) to support the agency's FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research efforts. The contract has a period of performance through March 30, 2024 and utilizes cost-reimbursement pricing with no fee. UMD is providing research, analysis, and other professional services related to the COVID-19 pandemic response. This award...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) to provide MPOX surveillance samples. The contract has a ceiling value of $44,750.00 and a period of performance through September 13, 2024. UMB is a prominent academic health sciences institution that has a history of providing specialized biomedical research, clinical services, and laboratory support to federal agencies. This contract...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Maryland, Baltimore (UMB) for $243,158.00 to provide best practices and preferred uses of refusable EHMR in healthcare. The contract is not associated with a larger vehicle and does not have a set-aside designation. As a public university and medical center, UMB provides a range of research, healthcare, and education services to...
- This is a $520,000 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the University of Maryland, Baltimore (UMB) for "UMD MOUSE PATHOGENESIS AND THERAPEUTIC DEVELOPMENT FOR SARS-COV-2". The contract was issued under ASPR's Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA), which solicited proposals for areas of interest related to medical countermeasure...
This federal contract award, issued by the Centers for Disease Control and Prevention (CDC), tasks the University of Maryland, Baltimore (UMB) to conduct systems serology and cellular marker studies as part of a controlled human infection model (CHIM) trial for pertussis. Under this $1,160,383 firm-fixed-price definitive contract, UMB will perform a range of antibody profiling assays on samples from 30 adult participants before and after pertussis challenge. The data generated will then be analyzed using machine learning approaches. UMB has subcontracted portions of the work to Massachusetts General Hospital (MGH), which will also perform the specified serology and cellular assays. The ultimate completion date for this effort is September 14, 2025. This contract was awarded without any set-aside designations.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
20974KB4970S | The General Hospital Corporation | Definitive Contract 75D30122C15467 | $294.0k | 1/11/24 | |
20974KB2828S | The General Hospital Corporation | Definitive Contract 75D30122C15467 | $294.0k | 7/11/23 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 9/16/24 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 7/7/23 | |
| P00001 | Other Administrative Action | $0 | 10/14/22 | |
| Not listed | Not listed | $1.2m | 9/16/22 |